P&K Skin Research Center Co. Ltd Cash Flow Reinvestment Rate

Latest as of September 2025: 0.72x

P&K Skin Research Center Co. Ltd cash flow reinvestment rate. P&K Skin Research Center Co. Ltd (347740) has a Cash Flow Reinvestment Rate of 0.72x as of September 2025, reinvesting ₩1.22 Billion (capex ₩281.11 Million plus investments ₩937.29 Million) from operating cash flow of ₩1.70 Billion. Explore 347740 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.72x
(Capex + Investments) / Operating CF

Total Reinvested

₩1.22 Billion
Capex + Investments

Operating Cash Flow

₩1.70 Billion
KRW

Capital Expenditures

₩281.11 Million
KRW

Cash Flow Reinvestment Rate of P&K Skin Research Center Co. Ltd (2018–2024)

Cash flow reinvestment rate of P&K Skin Research Center Co. Ltd from 2018 to 2024. Historical reinvestment intensity for P&K Skin Research Center Co. Ltd across 7 annual periods. Explore reinvestment intensity of P&K Skin Research Center Co. Ltd to see what proportion of operating cash flow is directed to capital expenditures.

P&K Skin Research Center Co. Ltd Cash Flow Reinvestment Rate by Year (2018–2024)

P&K Skin Research Center Co. Ltd cash flow reinvestment rate by year from 2018 to 2024. Year-by-year capital reinvestment analysis for P&K Skin Research Center Co. Ltd. For the full cash flow conversion analysis, see cash flow conversion of P&K Skin Research Center Co. Ltd.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 1.05x ₩9.50 Billion ₩9.03 Billion ₩622.12 Million ▲ +130.4%
2023 0.46x ₩2.53 Billion ₩5.55 Billion ₩1.56 Billion ▼ -39.7%
2022 0.76x ₩5.68 Billion ₩7.51 Billion ₩1.36 Billion ▼ -53.9%
2021 1.64x ₩12.62 Billion ₩7.70 Billion ₩2.81 Billion ▼ -62.1%
2020 4.33x ₩37.52 Billion ₩8.67 Billion ₩1.05 Billion ▲ +631.7%
2019 0.59x ₩3.84 Billion ₩6.49 Billion ₩541.19 Million ▲ +284.6%
2018 0.15x ₩655.80 Million ₩4.26 Billion ₩655.80 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow